Estriol: Women's Choice vs. A Manufacturer's Greed
Download in electronic PDF format for $65
Abstract: The U.S. Food and Drug Administration recently took action to† hal4 the compounding of hormone preparations that contain estriol, an action requested in a citizen petition filed by Wyeth
Pharmaceuticals. If the Food and Drug Administration, with the support of Wyeth, is successful
in its efforts, women throughout the U.S. who rely on compounded hormones containing estriol will have to discontinue their prescribed treatment. The International Academy of Compounding Pharmacists is engaged in ongoing outreach to ensure that members of Congress recognize the importance of protecting pharmacy compounding for the health and well-being of their constituents. Significant progress has been made with the recent introduction of a congressional resolution in support of estriol.
Related Keywords:
Jennifer Goodrum, estriol, U.S. Food and Drug Administration, FDA, regulation, Wyeth, bioidentical hormone replacement therapy, estrogen, BHRT
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
|
Nov/Dec 2001
Pg. 462-464
|
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
|
Mar/Apr 2002
Pg. 142-146
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R, Zava David T
|
Jul/Aug 2003
Pg. 250-256
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy
Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
|
Jul/Aug 2004
Pg. 313-319
|
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Lorentzen Jean
|
Sep/Oct 2001
Pg. 336-338
|
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
|
Jan/Feb 2019
Pg. 32-33
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
|
Nov/Dec 2016
Pg. 447-454
|
